XML 27 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Quarterly Financial Data (unaudited) (Tables)
12 Months Ended
Dec. 31, 2012
Quarterly Financial Data (unaudited)  
Schedule of quarterly results of operations

 

 
  Three Months Ended  
 
  March 31,
2012
  June 30,
2012
  September 30,
2012
  December 31,
2012
 
 
  (in thousands, except shares and per share data)
 

Revenues:

                         

License and milestone revenue

  $   $   $   $  

Cost sharing reimbursements, net

                 
                   

Total collaboration revenues

                 

Grant revenue

    147              
                   

Total revenues

    147              

Operating expenses:

                         

Research and development

    12,066     11,252     11,743     14,351  

General and administrative

    2,646     2,882     2,796     3,352  
                   

Total operating expenses

    14,712     14,134     14,539     17,703  
                   

Loss from operations

    (14,565 )   (14,134 )   (14,539 )   (17,703 )

Interest expense, net

    (486 )   (486 )   (457 )   (420 )
                   

Net loss

  $ (15,051 ) $ (14,620 ) $ (14,996 ) $ (18,123 )
                   

Basic and diluted net loss per common share

  $ (0.27 ) $ (0.25 ) $ (0.25 ) $ (0.29 )
                   

Basic and diluted weighted average number of common shares outstanding

    56,366,992     57,650,412     60,661,720     62,914,546  


 

 
  Three Months Ended  
 
  March 31,
2011
  June 30,
2011
  September 30,
2011
  December 31,
2011
 
 
  (in thousands, except shares and per share data)
 

Revenues:

                         

License and milestone revenue

  $ 1,143   $ 1,143   $ 1,143   $ 3,302  

Cost sharing reimbursements, net

                 
                   

Total collaboration revenues

    1,143     1,143     1,143     3,302  

Grant revenue

        211     521     121  
                   

Total revenues

    1,143     1,354     1,664     3,423  

Operating expenses:

                         

Research and development

    9,436     10,417     10,751     10,859  

General and administrative

    2,673     2,946     3,131     2,803  
                   

Total operating expenses

    12,109     13,363     13,882     13,662  
                   

Loss from operations

    (10,966 )   (12,009 )   (12,218 )   (10,239 )

Interest expense, net

    (435 )   (493 )   (516 )   (504 )
                   

Net loss

  $ (11,401 ) $ (12,502 ) $ (12,734 ) $ (10,743 )
                   

Basic and diluted net loss per common share

  $ (0.27 ) $ (0.26 ) $ (0.26 ) $ (0.22 )
                   

Basic and diluted weighted average number of common shares outstanding

    42,008,818     47,845,315     49,403,589     49,426,806